A Study to Determine the Bioequivalence of Two Doses of Tafamidis
Clinical trial NCT04575116 · COMPLETED
Trial details
- NCT number
- NCT04575116
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2021-02-23
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.